Galactosed and Reduction-Responsive Nanoparticles Assembled from Trimethylchitosan–Camptothecin Conjugates for Enhanced Hepatocellular Carcinoma Therapy

The targeted delivery of drugs to tumor cells and prevention of premature release before reaching the target is one of the key challenges to developing nanomedicines. In this paper, galactose decorated trimethyl chitosan (GT)–camptothecin (CPT) prodrug nanoparticles (GT-ss-CPT NPs) were prepared fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Chen, Qin, Jingcan, Liu, Xinlong, Kong, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316716/
https://www.ncbi.nlm.nih.gov/pubmed/35890209
http://dx.doi.org/10.3390/pharmaceutics14071315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316716/
https://www.ncbi.nlm.nih.gov/pubmed/35890209
http://dx.doi.org/10.3390/pharmaceutics14071315

Ejemplares similares